• Article highlight
  • Article tables
  • Article images

Article History

Received : 26-10-2021

Accepted : 18-11-2021



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 554

PDF Downloaded: 447


Get Permission UJ-P N'guessan, Coulibaly, and Ouattara: Pharmacotherapy of gastrointestinal strongylosis of small ruminants: An update


Introduction

The gastrointestinal strongylosis of small ruminants or digestive strongylosis are parasitic diseases caused by nematodes within the herd, especially in sheep and goats.1 These digestive helminthoses usually evolve during the grazing period and mainly result in gastroenteritis with rebellious diarrhea or the evolution of anemic syndrome.2 In fact, their wide geographical distribution and their pathogenic nature lead to significant economic losses in flocks.3 The threat of gastrointestinal parasitosis in small ruminants is all the more alarming as livestock production contributes to 8 to 15% of the Gross Domestic Product (GDP) in West Africa. Moreover, grazing ruminants production accounts for 34% of the cash income of rural households.4 The objective of most animal parasite control strategies is not to eliminate the offending pests altogether, but to keep the infesting population below a threshold above which it would inflict harmful effects on the host population.5 Anthelmintic drugs are commonly used for either prophylactic purposes, in which timing of treatment is based on knowledge of epidemiology, or for therapeutic purposes to treat existing infections or clinical epidemics. Since the advent of anthelmintics, considerable progress has been made in the use of various animal pest medications.6, 7, 8 The aim of this review is to present the pharmacochemical aspects of anthelmintics currently used for the management of strongylosis in small ruminants and the perspectives of drug research for this parasitosis.

History and classification

Many chemical compounds and plant metabolites have toxic effects on parasitic nematodes. Although most, including drugs such as sodium arsenite, tetrachlorethylene, carbon tetrachloride, carbon disulfide, copper sulphate and nicotine sulphate, were used earlier, these deworming drugs are potentially as toxic to parasites as to their hosts. The economic importance of breeding led to the development in 1939 of the first synthetic anthelmintic, Phenothiazine or Thiodiphenylamine (Figure 1).9 The introduction of phenothiazine into therapeutics, followed in the early 1960s, by the discovery and development of the first benzimidazole drug with a broader spectrum of action on gastrointestinal nematodes. Thiabendazole has helped to make sheep production profitable in some parts of the world.10 

In addition to benzimidazoles, several other anthelmintics have been discovered and placed on the market, including imidazothiazoles. The first drug in this class of nicotinic receptor agonist, levamisole, was introduced in the early 1970s.11 In 1977, a new anthelmintic of the salicylanilide class was discovered: Closantel.12 Therefore, Closantel and Nitroxinil from the nitrophenol group (discovered in 1966) are available and have a narrow spectrum of activity against H. contortus.13

From 1975, research on antiparasitics was directed to substances of natural origin, radically different from those used in veterinary therapy. This led to the discovery of the chemical class of macrocyclic lactones which are polyvalent antiparasitic active both in human medicine, especially in filariasis and veterinary medicine against gastrointestinal and respiratory nematodes in ruminants, equines, swine and the domestic animals. The first macrocyclic lactone drug, ivermectin, was discovered by Satoshi Omura and William Campbell and introduced therapeutically in the early 1980s.14 In 2015, these researchers received the Nobel Prize for Medicine for this groundbreaking discovery.15

One of the last anthelmintic molecules that was developed in 2008 is Monepantel. This represents the precursor of a fifth family introduced on the market, that of the amino-acetonitrile derivatives and was presented as a solution in case of multiple resistance to anthelmintics.16 Other drugs such as Derquantel (spiroindole), in combination with abamectin are also used. In total, according to their mode of action, the chimioth ed therapy of strongylosis ruminants traditionally based on four main pharmacological classes of broad-spectrum anthelmintics that are:

  1. The benzimidazoles inhibiting the polymerization of β-tubulins,

  2. Cholinomimetic imidazothiazoles and tetrahydropyrimidines,

  3. The macrocyclic lactones activating the glutamate-dependent chloride channels,

  4. Salicylanilides and nitrophenols as inhibitors of oxidative phosphorylation

To those, we should add the chemical classes of amino acetonitriles, the spiroindoles and cyclooctadepsipeptides that contain molecules used in combination with other pesticides.

Figure 1

Main anthelmintics

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cf6b7f9-781b-47b4-8696-33ebc2ec560fimage1.png

Classical Anthelmintics

Benzimidazoles and probenzimidazoles

Definition-Structure

Benzimidazoles and anthelmintic probenzimidazoles have the distinction of being used in both human medicine and veterinary medicine. This chemical series is characterized by the presence of the benzimidazole ring used as a heterocyclic support.17 It includes four subgroups, however benzimidazoles available in small ruminants belong to the first two categories of compounds18 (Figure 2) :

  1. Probenzimidazoles which have the ability to release the corresponding benzimidazoles as active metabolites in a biological medium. Developed to improve the solubility of benzimidazoles in water and their absorption, they have 2 representatives in veterinary medicine : Febantel and Nétobimin.

  2. The 2-carbamoyl-benzimidazoles derivatives, substituted in position 2 by a carbamate and in position 5 by various modulators. They are the most numerous and the most important. Those used in veterinary medicine are: Albendazole, Oxfendazole, Fenbendazole, Oxibendazole, Flubendazole and Mebendazole (in combination).

  3. A derivative substituted in position 2 by a thioether function, in position 5 by a halogen and in position 6 by a phenoxyl group: Triclabendazole

  4. A Derivative substituted in position 2 by a thiazole-type heterocycle: Thiabendazole

They are marketed in the form of oral powder, oral and injectable solutions or suspensions, intraruminal boluses or medicated premixes.18

Figure 2

 Structures of some benzimidazole and probenzimidazole anthelmintics

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cf6b7f9-781b-47b4-8696-33ebc2ec560fimage2.png

Mechanism of action

Benzimidazoles act directly on the worms while probenzimidazoles are administered to the animal in the form of prodrugs converted into active molecules by enzymatic reactions, which generally take place in the liver. 6

These drugs would bind to β-tubulin proteins in the cytoplasm of intestinal nematode cells, thereby inhibiting dimerization with α-tubulin during microtubule formation without altering those of host.19 Since microtubules are the structural base of the cytoskeleton, these molecules induce lesions of the intestinal cells in the worm and thus stop the worms' feeding. The nematodes thus susceptible die of hunger.20 In addition, these drugs are ovicidal, by inhibiting the hatching of nematode eggs by a destructive antimitotic effect of the microtubule network of the parasite without altering that of the host.6

Spectrum of action and indications

In veterinary medicine, benzimidazole derivatives are used in the treatment of respiratory nematode infections (especially against worm bronchitis due to strongyles), ascariasis, strongylosis of the small intestine and the large intestine. For digestive strongyloses, benzimidazole derivatives are not only active on adult forms, but also on immature forms. The most sensitive genera are Haemonchus, Ostertagia, Trichostrongylus, Cooperia, Nematodirus , Chabertia and Oesophagostomum.21

 Table 1 Summarizes the action spectra of all active anthelmintic molecules in gastrointestinal strongyles.

Table 1

Main families, anthelmintic molecules and their spectrum of action against the main gastrointestinal nematodes of small ruminants

Families

Anthelmintics

Action spectrum

Benzimidazole

All

Ad, L4 and hypobiosis of Hc and Tc 

Imidazothiazoles

Levamisole

Ad and L4 of Hc and Tc

Tetrahydropyrimidine

Pyrantel

Ad

Salicylanides

All

Ad, L4 and hypobiosis of Hc

Nitrophenols

Nitroxinil

Ad, L4 and hypobiosis of Hc

Lactones macrocyclic

Ivermectin doramectin moxidectin

Ad and L4 of Hc, Tc and Ta Ad, L4 and hypobiosis of Hc and Tc Ad, L4 and hypobiosis of Hc, Tc and Ta

Cyclooctadepsipeptides

Emodepside

Ad and L4 of Hc

Spiroindoles

Derquantel (+ Abamectine)

Ad, L4 and hypobiosis of Hc, Tc and Ta + Resistant and multiresistant Nematodes

Aminoacetonitrile derivatives

Monepantel

Ad, L4 and hypobiosis of Hc, Tc, Ta,

[i] Ad: adult; L4: 4eme stade larvaire, Hc: Haemonchus contortus ; Tc: Teladorsagia circumcincta ; Ta: Trichostrongylus axi

Macrocyclic lactones

Definition — structure

Macrocyclic lactones represent a homogeneous family of anthelmintics of natural origin. They are endectocides derived from actinomycete fermentation of the genus Streptomyces. The species Streptomyces avermitilis, Streptomyces hygroscopicus and Streptomyces cyaneogriseus generate during their growth many compounds that fall into two sub-families: avermectins (eg Ivermectin (Figure 3), Doramectin, Abamectin etc.) and milbemycins (eg Moxidectin).21 The name avermectin derives from its properties acaricide, insecticide and nematocide: a for anti, verm for worm and ect for ectoparasite.22 Abamectin (avermectin B1) is more active on nematodes than Ivermectin but less effective on arthropods.

From the point of view of their chemical constitution, they are 16-membered macrolides which all have a complex structure comprising a lactone heterocycle. The major structural difference between the two groups is the presence of the disaccharide moiety ( bisoleandrosyloxy substituent) on carbon number 13 (C13) avermectins. Milbemycins are deprived of it; they are therefore deglycosylated avermectins (aglycones of avermectins) (Figure 3).23 α-milbemycins retain the furan ring while for β, the C6-O bond no longer exists.

Figure 3

 Structure of Milbemycin α-1 and Ivermectin

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/0cf6b7f9-781b-47b4-8696-33ebc2ec560fimage3.png

Mechanism of action

Despite the structural differences between avermectins and milbemycins, the main mechanism of action is similar and involves activation of the glutamate-dependent chloride (GluCl) channels of the neuromuscular cell membrane of nematode (absent in mammals).6 Incidentally, they have effects on gamma-aminobutyric acid (GABACl) receptors. This allosteric binding to the subunits of the GluCl and GABACl channels would cause their opening and an increase in membrane permeability to chloride ions, which is time-dependent.20 Then occur paralysis pharynx and somatic muscle and death of nematodes.23 In addition, a study of Caenorhabditis elegans revealed that the levamisole-sensitive receptor (L-AChR), one of the major excitatory receptors involved in parasitic locomotion, is profoundly inhibited by ivermectin.20 This would lead to a hyperpolarization of nerve and muscle cells causing reduction of pharyngeal pumping, flaccid paralysis of muscles and effects on the body of the uterus. These effects result in an inability to feed, move or lay eggs, respectively.24, 25

It has been proven that apart from this classical mechanism of action, Ivermectin and Moxidectin have an action mediated in part by PGP transport proteins.26

Spectrum of action and indications

Macrocyclic lactones are indicated for the treatment of gastrointestinal, respiratory and renal nematodoses in ruminants. The most sensitive parasites are strongyles (Bunostomum, Charbertia, Haemonchus, Oesophagostomum, Ostertagia ostertagi, Trichostrongylus adult and immature). 22 Moxidectin has the distinction of being effective and protecting against reinfestations by abomasum parasites for at least 5 weeks 23 (Table 1).

Salicylanides

Definition- structure

Salicy lanilides represent a homogenous class of anthelmintics, characterized by an amide function resulting from condensation between salicylic acid derivatives and aniline. The substituents of the phenyl groups are most often groups recognized as contributing to antiseptic or antiparasitic activities. : halo (Cl, Br, I), nitro, p- chlorophenoxyl. 17 This family includes four molecules but only one is currently used in the treatment of strongyles in ruminants (Figure 1). 18

Mechanism of action

At therapeutic doses, they are proton ionophores, specifically decoupling the mitochondrial oxidative phosphorylation of Adenosine Diphosphate (ADP), thus decreasing the synthesis of adenosine triphosphate 19, 21 (ATP). Enzymatic systems are then disturbed, resulting in energy depletion. In addition, the resulting blockage of the Krebs cycle results in the accumulation of lactic acid. This accumulation severely increases the disturbances of parasite metabolism which becomes sensitive to the proteolytic enzymes of the host.17 The action is immediate and prolonged (up to 35 days against H. contortus), because these molecules are highly related (> 99%) to plasma proteins.19

Spectrum of action and indications

These compounds are mainly used as douvicides but some of them are nematocides. They are active against H. contortus. Closantel is also very effective against adult-onset haematophagous strongles such as Haemonchus and Bunostomum in sheep. It is used as a substitute drug for the treatment of nematode infections caused by isolates of nematodes resistant to Ivermectin, Benzimidazole, Levamisole and Morantel.17

Nitrophenols

Definition- Structure

Still called halogenated phenols, it is a class of synthetic anthelmintic mainly represented by Nitroxinil. It has in its structure a phenol group substituted in ortho (2 and 2 'positions) with a nitro and a halogen and in para (4 position) by a nitrile function 13 (Figure 1).

Action mechanism

These are just like Salicylanilides, proton ionophores specifically decoupling the oxidative phosphorylation of mitochondria from the parasite's digestive cells without affecting those of the host. Enzymatic systems are disrupted, resulting in an energy depletion causing the death of the parasite.

Spectrum of action and indications

Nitroxinil has very marked anthelmintic properties:

  1. With regard to the moat of the genus Fasciola (hepatica and gigantica ,

  2. With regard to numerous hematophagous nematodes, parasites of ruminants

It is used in the treatment of gastro-intestinal fascioliasis and nematodoses in cattle and sheep (Table 1).27

Imidazothiazoles

Definition — structure

Imidazothiazoles are a class of compounds anthelmintics active against gastrointestinal strongyles in cattle and pigs, whether in adult or larval form.17 These active principles have in their structure animidazole nucleus attached to a thiazole nucleus, hence their name imidazothiazole. At present, two compounds are used therapeutically: Tetramisole, used in racemic form and levamisole, its laevorotatory isomer 10 times more active (Figure 1).17

Mechanism of action

These are cholinomimetics. They act selectively as agonists of nicotinic acetylcholine receptors (nAChRs) at the synapses of nematode muscle cells. They preferentially activate the 35pS channels (subtype L) and induce the opening of the non-specific ion channels permeable to Na+ and Ca2+. 28 Calcium entered into the sarcoplasmic reticulum via nAChRs also induces the opening of calcium channels dependent voltages (VACC). The calcium present in the sarcoplasmic reticulum produces either directly or by activation of ryanodine receptors (RyR) a membrane depolarization resulting in muscle contraction.28 This results in severe and reversible spastic paralysis of the parasite which is then expelled from the host by peristalsis.

Spectrum of action and indications

Imidazothiazoles are active in gastrointestinal strongyloses in ruminants, pigs and rabbits. The efficacy is very good on Haemonchus, Trichostrongylus, Cooperia, Chabertia, adult and immature Oesophagostomum 6, 17 (Table 1).

Tetrahydropyrimidines

Definition- structure

The tetrahydropyrimidine are a class of anthelmintics has wide spectrum of action. They possess the1, 2, 3, 4, 5, 6 nucleus, tetrahydropyrimidine methylated on nitrogen 1, and C2-connected to a vinylthienyl or stryryl residue whose ethylenic chain is of trans configuration are available as tartrate or pamoate.17 This class has three molecules, but only pyrantel pamoate is commonly used.

Mechanism of action

These are cholinergic agonists that bind to the nicotinic acetylcholine receptors of gastrointestinal nematodes. This fixation induces a change in post-synaptic membrane permeability causing muscle contraction, followed by marked spastic paralysis of worms.6

Spectrum of action and indications

Their spectrum of activity extends to gastrointestinal strongles and respiratory strangles29. They are indicated for treating gastrointestinal strongyloses, but they have minimal activity against immature forms and stopped larval stages (L4).6

Anthelminthics Recently Introduced

Aminoacetonitrile derivatives

Definition-structure

Aminoacetonitriles are a new class of synthetic anthelmintics. Their specificity lies in their effectiveness vis-à-vis strains resistant to other anthelmintics. The only representative currently used in veterinary therapy is Monepantel (Figure 1).6 From the structural point of view, this amino acetonitrile comprises an asymmetric carbon at the level of acetonitrile, the four substituents of which are a nitrile function, a methyl group (5-cyano-2- (trifluoromethyl) phenoxy) methyl and (4-trifluoromethylthio) benzamide.

Mechanism of action

Monepantel would act on the nicotinic cholinergic receptor specific for nematodes of the DEG-3 subfamily. Monepantel does not activate monovalent cation channels itself, it substantially increases late currents after choline channel activation. Aminoacetonitriles are positive allosteric modulators of H. contortus DEG-3 receptors.6 They cause a hyper contraction of the bodily muscles, which leads to spasmodic contractions of the anterior portion of the pharynx, to paralysis and then to the death of the parasite.16, 28

Spectrum of action and indications

Monepantel has a broad spectrum of activity against gastrointestinal nematodes, sheep, including adults and L4 larvae of the most important species. The main characteristic of this molecule is its good efficacy against strains of nematodes resistant to benzimidazoles, levamisole, macrocyclic lactones or even against multiresistant strains.

These efficacy results are complemented by good tolerance and low toxicity for mammals.16, 28 In addition, Monepantel is considered non-toxic to the environment (soil microflora, aquatic organisms, manure organisms, vegetation, etc).

Monepantel is recommended for the treatment and control of gastrointestinal nematodoses in sheep, especially when they are resistant to one of the three classes of broad-spectrum anthelmintics.28

Spiroindoles

Definition-structure

The main representative of this class is Derquantel. It is a 2-desoxyparaherquamide, semi-synthetic analogue obtained by chemical reduction of paraherquamide, a fermentation product of Penicillium simplicissimum.30 Derquantel is the first spiroindole anthelmintic that was marketed in 2010 in veterinary medicine in combination with a macrocyclic lactone, abamectin (Startect®).

Table 2

Biological targets for anthelmintic classes acting through ion channels31, 32

Biological targets

Classes of anthelmintics

Species of nematode / genes found

Glutamate-dependent chloride channels (GluCl)

Macrocyclic lactones

C. elegans / glc-1, glc-2, glc-3, apr-14ba (gbr-2b), Apr-15

H. contortus / Hco-Glc-2b (HG4), HCO-glc-3b, HCO-April-14 b (HG3, GluCla3B), HCO-glc-5 (GluCla, HG5) Hco-Glc-6 b

Nicotinic Receptors of Acethylcholine (nAChR)

Imidazothiazoles

C. elegans / nAChR L-type: lev-1, lev-8, unc-29, unc-38, unc-63. n-type nAChR: acr-16

Tetrahydropyrimidine

H. contortus / L nAChR Type: Hco-acr-8, Hco-yeast-1c, HCO-29, unc-d, HCO-unc-38, unc-HCO-63.

Spiroindoles

A. suum / nAChR L-type: unc-29, unc-38. n-type nAChR: acr-26R

Cholinergic receptors

Amino-acetonitrile

C. elegans / acr-23, deg-3, des-2

H. contortus / Hco mptl-e-1, HCO-deg-3, HCO-deg-2

SLO-1 potassium channels and Latrophilin receptors

Cyclooctadepsipeptides

C. elegans / slo-1, lat-1

H. contortus / Hco-slo-1, Hco-lat-1 (Hc-110R)

Mechanism of action

Three nicotinic receptors were identified in Ascaris suum: the subtype N (activated by nicotine), the subtype L (activated by levamisole and pyrantel) and the subtype B (activated by bephenium) respectively corresponding to 24pS, 35pS and 45pS channels.30, 33 Derquantel acts as a selective and competitive antagonist of nicotinic acetylcholine receptors by interfering with the 35pS (subtype L) and 45-pS (subtype B) channels leading to flaccid paralysis nematodes that are then expelled from the host.6 The antagonist effect of Derquantel est plus important in sensitive receiver Pyrantel on the sensitive receiver Levamisole, the Derquantel also remains active on some resistant strains Levamisole.28

Spectrum of action and indications

Derquantel is active against L4 adults and immature forms of all major gastrointestinal nematodes, namely Haemonchus contortus, Teladorsagia circumcincta, Trichostrongylus axi, Trichostrongylus colubriformis, Nematodirus spathiger, etc. The association with Abamectin broadens its spectrum of activity and larval stages hypobiotiques.28 This combination has demonstrated good efficacy against a range of mutant nematodes of variable resistance status and efficacy against resistant and multi-resistant nematodes.34

Cyclooctadepsipeptides

Definition- structure

Emodepside is the only representative of this family of cyclooctadepsipeptides currently available (Figure 1). It is a semi-synthetic compound of a derivative of fermentation product PF1022A of Mycelia sterilia mushroom.35 He was introduced to therapy in 2001.19

Mechanism of action

Two modes of action for Emodepside have been described; firstly, binding to presynaptic G protein-coupled receptors (HC110-R) and secondly pre- and post-synaptic interactions with a Ca2 + activated K +ion channel (SLO-1).20,28 As a result, binding to latrophiline receptor and ion channel SLO-1 leads to inhibition of pharyngeal pumping, then occur atonic paralysis and death of the worm.18

Spectrum of action and indications

Emodepside is available in therapeutic combination with Praziquantel (a schistosomicide) in Profender. It is used as a spot-on in cats and tablet in dogs against the main gastrointestinal nematodes and cestodes. Its efficacy has also been demonstrated against some small strongyles (cyathostomes) in horses, against Trichostrongylus colubriformis and Haemonchus contortus in sheep and against Dictyocaulus viviparus in cattle. Due to its new dual mode of action, Emodepside is effective against nematodes resistant to classical anthelmintics.36, 37

Ionic Channels As Potential Targets for New Anthelmintics

Many anthelmintic drugs used today act on the nervous system of nematodes (Table 2). Ionic channels as targets have certain advantages. Indeed, anthelmintics acting through this, quickly paralyze worms and fight effectively and quickly the infection. Thus, the macrocyclic lactones bind to an allosteric site of the glutamate-dependent chloride channels, either by directly activating the channel or by amplifying the effect of the neurotransmitter physiological, glutamate.31

Many anthelmintics both old and new, including aminoacetonitrile derivatives, act as agonists of nicotinic acetylcholine receptors. Derquantel is an antagonist of these receptors. The Emodepside has multiple effects, affecting both a potassium channel and a receptor coupled to the pre-synaptic G protein.31

Conclusion

Veterinary helminths and their treatment are a socio-economic issue because they remain the main cause of economic losses in livestock farming. This situation persists for two main reasons. The first is the low level of veterinary coverage against helminths in small ruminants. The second reason is mainly related to the emergence of parasitic strains resistant to anthelmintic drugs, especially 2-carbamoyl-benzimidazoles. Indeed, despite their efficacy, these anthelmintics present several limitations in their practical use. Due to the elimination of some anthelmintics or their metabolites in milk, their use in small ruminant dairy species is limited. Only Febantel, Oxfendazole and Fenbendazole are used during lactation. In addition, some of these anthelmintics, namely macrocyclic lactones, are toxic to coprophagous beetles that are fertilizing agents in grassland fertilizers. Finally, due to the increasing appearance of helminth populations resistant to existing antiparasitic drugs, and in the search for new effective molecules with innovative mechanisms of action to allow a more durable control of this parasitism, nicotinic acetylcholine receptors may be selected as a preferred target for the development of new synthetic molecules.

Source of Funding

None. 

Conflict of Interest

None.

References

1 

A P Robertson S K Buxton S Puttachary S M Williamson A J Wolstenholme C Neveu Antinematodal Drugs - Modes of Action and Resistance: And Worms Will Not Come to Thee (Shakespeare: Cymbeline : IV, ii)Parasitic Helminths: Targets, Screens, Drugs Vaccines20122338210.1002/9783527652969.ch14Wiley-Blackwell

2 

A C Kotze P W Hunt P Skuce G V S-Himmelstjerna R J Martin H Sager Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug / receptor interactionsInt J Parasitol Drugs Drug Resist2014431648410.1016/j.ijpddr.2014.07.007

3 

P D Constable K W Hinchcliff S H Done W Gruenberg Veterinary Medicine A textbook of the diseases of cattle, horses, sheep, pigs and goats - two-volume set11201660313

4 

P J Hotez L Savioli A Fenwick Neglected tropical diseases of the Middle East and North Africa: review of their prevalance, distribution, and opportunities for controlPLoS Negl Trop Dis201262147510.1371/journal.pntd.0001475

5 

J Charlier M V D Voort F Kenyon P Skuce J Vercruysse Chasing helminths and their economic impact on farmed ruminantsTrends in Parasitol2014730361810.1016/j.pt.2014.04.009

6 

M J B Kamuanga J Somda Y Sanon CSAO/OCDE. Livestock and regional market in the Sahel and West Africa2008170https://www.oecd.org/swac/publications/41848366.pdf

7 

H Hoste J P Guitard J C Pons Pâturage mixte entre ovins et bovins : intérêts dans la gestion du parasitisme par les strongles gastro-intestinauxAlter-Agri2003612023

8 

C E Lanusse L I Alvarez A L Lifschitz Gaining Insights Into the Pharmacology of Anthelmintics Using Haemonchus contortus as a Model NematodeAdv Parasitol20169346551810.1016/bs.apar.2016.02.014

9 

T Getachew P Dorchies P Jacquiet Trends and challenges in the effective and sustainable control of Haemonchus contortus infection in sheep: reviewParasite200714131410.1051/parasite/2007141003

10 

M A Taylor R L Coop R L Wall Veterinary Parasitology Veterinary Parasitology3rd 2013256

11 

H M Gordon Phenothiazine as an anthelminticAus Vet J19451905

12 

H D Brown A R Matzuk I R Ilves L H Peterson S A Harris L H Sarett Antiparasitic drugs IV. 2- ( 4'-Thiazolyl) -benzimidazole a new anthelminticJ. Am Chem Soc196183717649

13 

Gc Coles J M East S N Jenkins The mechanism of action of the anthelmintic levamisoleGen Pharmacol 19756430922

14 

M Janssen V K Sipido Antiparasitic salicylanilide derivativesUnited States Patent19774218

15 

M Davis J Rosenbaum D E Wright Chemotherapy of fascioliasis. II. 4-Cyano-2-iodo-6-nitrophenol (nitroxynil) and related compoundsJ Sci Food Agric1969201274854

16 

M J Turner J M Schaeffer Mode of action of ivermectin19897388

17 

M Danis D R Lenoble Medicine 2015 for tropical countries: ivermectin, an antiparasitic drug undeniable against filariasisMed Sci2016321110510.1051/medsci/20163201018

18 

R Kaminsky N Gauvry W S Schorderet T Skripsky J Bouvier A Wenger Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidateParasitol Res200810349314010.1007/s00436-008-1080-7

19 

C Noireau Therapeutic chemistry.21998544

20 

L Ed Dictionary of Veterinary Medicines and animal health products (DMV)2020162531

21 

S P Thomas Recent data on resistance to anthelmintics in the gastrointestinal strongyles of ruminants. J Vet Intern Med2003202100

22 

W C Campbell Benzimidazoles: veterinary usesParasitol Today199064130310.1016/0169-4758(90)90231-r

23 

W L Shoop H Mrozik M H Fisher Structure and activity of avermectins and milbemycins in animal healthVet Parasitol19955921395610.1016/0304-4017(94)00743-v

24 

R Prichard C Ménez Moxidectin and the avermectins: consanguinity but not identityInt J Parasitol Drugs Drug Resist20121421345310.1016/j.ijpddr.2012.04.001

25 

J P Arena K Liu H Mrozik E G Frazier D F Cully The mechanism of action of avermectins in Caenorhabditis elegans : correlation between activation of sensitive chloride current, membrane binding, and biological activityJ Parasitol199581228694

26 

G E Swan The pharmacology of halogenated salicylanilides and their anthelmintic use in animalsJI S Afr Vet Assoc Ass19997026170

27 

W J Blackhall H Y Liu M Xu R K Prichard R N Beech Selection at a glycoprotein gene in ivermectin and moxidectin-selected strains of Haemonchus contortusMol Biochem Parasitol199895219320110.1016/s0166-6851(98)00087-5

28 

M S Makkar Some pharmacological studies on nitroxynil (4-cyano-2-iodo-6-nitrophenol)Indian J Anim Res197482813

29 

C Chartier I Pors C Benoit Efficacy of pyrantel tartrate against experimental infections with Haemonchus contortus , Teladorsagia circumcincta and Trichostrongylus colubriformis in goatsVet Parasitol1995591697310.1016/0304-4017(94)00737-w

30 

D J Woods S J Maeder A P Robertson R J Martin T G Geary Discovery, Mode of Action, and Commercialization of DerquantelParasitic Helminths: Targets, Screens, Drugs Vaccin2012297307Wiley-Blackwell

31 

A J Wolstenholme Ion channels and receptor as targets for the control of parasitic nematodesInt J Parasitol Drugs Drug Resist20111121310.1016/j.ijpddr.2011.09.003

32 

L H Dye M Joyner V O'connor Nicotinic acetylcholine receptors: A comparison of the nAChRs of Caenorhabditis elegans and parasitic nematodesParasitol Int20136266062110.1016/j.parint.2013.03.004

33 

A P Robertson S M Trailovic T A Burns D P Thompson T G Geary Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscleJ Pharmacol Exp Ther200230238536010.1124/jpet.102.034272

34 

P R Little A Hodges S J Maeder N C Wirtherle D R Nicholas G G Cox Efficacy of the oral formulation of derquantel-abamectin against the adult and larval stages of nematodes in sheep, including anthelmintic-resistant strainsVet Parasitol20111812-41809310.1016/j.vetpar.2011.05.008

35 

T Sasaki M Takagi T Yaguchi S Miyadoh T Okada M Koyama A new anthelmintic cyclodepsipeptide PF1022AJ Antibio1992455692710.7164/antibiotics.45.692

36 

V S Himmelstjerna G Harder A Sangster N C Coles Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattleParasitology200513033435010.1017/s0031182004006523

37 

K Lees A Sluder N Shannan L Hammerland D Sattelle Ligand-Gated Ion Channels as Targets for Anthelmintic Drugs: Past, Current, and Future PerspectivesParasitic Helminths: Targets, Screens, Drugs Vaccines201262321



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.